Cargando…

Inhibition of the IFN Response by Bluetongue Virus: The Story So Far

Bluetongue virus (BTV) is the prototypical orbivirus that belongs to the Reoviridae family. BTV infection produces a disease in ruminants, particularly in sheep, that results in economic losses through reduced productivity. BTV is transmitted by the bite of Culicoides spp. midges and is nowadays dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas, José Manuel, Avia, Miguel, Martín, Verónica, Sevilla, Noemí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217435/ https://www.ncbi.nlm.nih.gov/pubmed/34168637 http://dx.doi.org/10.3389/fmicb.2021.692069

Ejemplares similares

The Interplay between Bluetongue Virus Infections and Adaptive Immunity
por: Rodríguez-Martín, Daniel, et al.
Publicado: (2021)

Vaccination With Recombinant Adenoviruses Expressing the Bluetongue Virus Subunits VP7 and VP2 Provides Protection Against Heterologous Virus Challenge
por: Rojas, José Manuel, et al.
Publicado: (2021)

Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses
por: Martín, Verónica, et al.
Publicado: (2015)

Vaccination as a Strategy to Prevent Bluetongue Virus Vertical Transmission
por: Rojas, José M., et al.
Publicado: (2021)

Diagnosing bluetongue virus in domestic ruminants: current perspectives
por: Rojas, José M, et al.
Publicado: (2019)

Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire
por: Rojas, José-Manuel, et al.
Publicado: (2017)

Complement Inhibition and COVID-19: The Story so Far
por: Fodil, Sofiane, et al.
Publicado: (2021)

QCD at ATLAS: The Story So Far
por: Newman, Paul
Publicado: (2011)

Biology Open: The story so far…
por: Raff, Jordan W., et al.
Publicado: (2015)

Diet and Vitiligo: The Story So Far
por: Dutta, Rajoshee R, et al.
Publicado: (2022)

Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection
por: Rojas, José Manuel, et al.
Publicado: (2017)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Vitamin D and hippocampal development-the story so far
por: Lardner, Anne L.
Publicado: (2015)

Bone targeted treatments in cancer – The story so far
por: Coleman, Robert
Publicado: (2016)

Stem Cell Therapy for Burns: Story so Far
por: Abdul Kareem, Najath, et al.
Publicado: (2021)

Contentious Issues in Gout Management: The Story so Far
por: Talaat, Mohamed, et al.
Publicado: (2021)

Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes
por: Rojas, José M, et al.
Publicado: (2014)

Peste des Petits Ruminants Virus Fusion and Hemagglutinin Proteins Trigger Antibody-Dependent Cell-Mediated Cytotoxicity in Infected Cells
por: Rojas, José M., et al.
Publicado: (2019)

Adenoviral delivery of soluble ovine OX40L or CD70 costimulatory molecules improves adaptive immune responses to a model antigen in sheep
por: Rojas, José M., et al.
Publicado: (2022)

Dose-dense chemotherapy for breast cancer: the story so far
por: Hudis, C
Publicado: (2000)

Reflections on dynamic consent in biomedical research: the story so far
por: Teare, Harriet J. A., et al.
Publicado: (2020)

Shapeshifting molecules: the story so far and the shape of things to come
por: Bismillah, Aisha N., et al.
Publicado: (2019)

Factors influencing phagocytosis of malaria parasites: the story so far
por: Chua, Caroline Lin Lin, et al.
Publicado: (2021)

Calixarene-Metal Complexes in Lactide Polymerization: The Story so Far
por: Sachdeva, Garima, et al.
Publicado: (2023)

IL-10: A Multifunctional Cytokine in Viral Infections
por: Rojas, José M., et al.
Publicado: (2017)

Oncolytic Bluetongue Viruses: Promise, Progress, and Perspectives
por: Li, Joseph K.-K.
Publicado: (2011)

The greatest story ever told so far: why are we here?
por: Krauss, Lawrence M
Publicado: (2017)

CAR T-cell immunotherapy of B-cell malignancy: the story so far
por: Halim, Leena, et al.
Publicado: (2020)

Neurological infection with SARS-CoV-2 — the story so far
por: Solomon, Tom
Publicado: (2021)

Big Data Analytics in urology: the story so far and the road ahead
por: Hameed, B. M. Zeeshan, et al.
Publicado: (2021)

Protein–DNA Interactions: The Story so Far and a New Method for Prediction
por: Jones, Susan, et al.
Publicado: (2003)

Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far
por: Jani, Meghna, et al.
Publicado: (2018)

Scoping Review of the Occupational Health and Safety Governance in Sudan: The Story So Far
por: Abdelrahim, Rasha A., et al.
Publicado: (2023)

Hemagglutinin protein of Peste des Petits Ruminants virus (PPRV) activates the innate immune response via Toll-like receptor 2 signaling
por: Rojas, José M., et al.
Publicado: (2021)

Codon Usage Bias Analysis of Bluetongue Virus Causing Livestock Infection
por: Yao, Xiaoting, et al.
Publicado: (2020)

Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway
por: Rojas, José M., et al.
Publicado: (2020)

Cancer stem cells and HER2 positive breast cancer: The story so far
por: Shah, Deep, et al.
Publicado: (2016)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

The Story So Far: How Embodied Cognition Advances Our Understanding of Meaning-Making
por: Galetzka, Cedric
Publicado: (2017)

Targeting the Gut Microbiota in Chagas Disease: What Do We Know so Far?
por: Duarte-Silva, Eduardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ab53gro81c6rbi6abkkeq3k67